Current Illinois CancerCare Clinical Trials

PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Study Number: C2321001

Study Summary:
A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 In The Treatment Of Adult Patients With Relapsed/Refractory Small Cell Lung Cancer (SCLC), Castration Resistant Prostate Cancer (CRPC) And Follicular Lymphoma (FL).

Status: Open

Open in Peoria ONLY at this time. Suspended SCLC and Prostate cohorts.

Study Coordinator(s)
  • Navigator Carrie, 309-243-3621 cgeoffroy@illinoiscancercare.com
  • Navigator Ashton, 309-243-3611 atodd@illinoiscancercare.com
  • Navigator Heather, 309-243-3661 hthulean@illinoiscancercare.com

Study Link

« Search Again